Harvard Bioscience, Inc. (NASDAQ:HBIO)
CAPS Rating:
A developer, manufacturer and marketer of a range of specialized products, primarily apparatus and scientific instruments, used to improve life science research at pharmaceutical & biotechnology companies, universities & government laboratories worldwide.
RSS Headlines
Fool UK
Recs
Limited downside with good upside potential but definitely not for the faint of heart.